Infusion Systems Market in Japan 2016-2020
SKU ID :TNV-10279446 | Published Date: 28-Jun-2016 | No. of pages: 62Description
TOC
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market profile: Japan
• Economy, business, and development
PART 06: Healthcare system in Japan
• Role of government
PART 07: Key insights
PART 08: Complications of infusion systems: A global perspective
• Background
• Incidence of HAIs
• CAUTIs
PART 09: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 10: Market segmentation by product
• General purpose or volumetric pumps
• Syringe drivers
• Patient-controlled analgesia pumps
• Ambulatory pumps
PART 11: Market segmentation by application
• Analgesia or pain management
• Diabetes
• Oncology
• Gastroenterology
• Hematology
• Pediatric or neonatology
PART 12: Market drivers
• High prevalence of chronic diseases
• Increasing use of chemotherapy
• Rise in geriatric population
• Favorable market conditions
PART 13: Impact of drivers
PART 14: Market challenges
• Complications of infusion systems
• Catheter-related bloodstream infections
• Regulatory concerns and product recalls
• Price wars
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Use of power-driven and closed infusion systems
• Availability of IT-enabled devices
• Focus on alternative site and homecare services
PART 17: Vendor landscape
• Competitive scenario
• B. Braun Melsungen
• Baxter
• BD
• Fresenius Kabi
• Hospira
• JMS
• Nipro
• Terumo
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
Exhibit 01: Product offerings
Exhibit 02: Acceptable pressure rates for infusion systems
Exhibit 03: Maximum resistance during infusion therapy
Exhibit 04: Japan: Facts and figures
Exhibit 05: Japan: Characteristics of market
Exhibit 06: Key strategies for market entry
Exhibit 07: Advantages and disadvantages of business models for vendors
Exhibit 08: Comparison of HAI in developed and middle and low income countries
Exhibit 09: Evidence-based risk factors for CAUTIs
Exhibit 10: Infusion systems market in Japan 2015-2020 ($ millions)
Exhibit 11: Market metrics for infusion systems in japan
Exhibit 12: Five forces analysis
Exhibit 13: Segmentation of infusion systems market in Japan by product
Exhibit 14: Metrics analysis of general purpose or volumetric pumps
Exhibit 15: Metrics analysis of syringe drivers
Exhibit 16: Metrics analysis of patient-controlled analgesia pumps
Exhibit 17: Metrics analysis of ambulatory pumps
Exhibit 18: Segmentation of infusion systems market in Japan by product 2015
Exhibit 19: Segmentation of infusion systems market in Japan by application
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: B. Braun Melsungen: Key takeaways
Exhibit 23: Baxter: Key takeaways
Exhibit 24: BD: Key takeaways
Exhibit 25: Fresenius Kabi: Key takeaways
Exhibit 26: Hospira: Key takeaways
Exhibit 27: JMS: Key takeaways
Exhibit 28: Nipro: Product offerings
Exhibit 29: Nipro: Key takeaways
Exhibit 30: Terumo: Product offerings
Exhibit 31: Terumo: Key takeaways
Exhibit 32: Other prominent vendors
Tables & Figures
Companies
B. Braun Melsungen, Baxter, BD, Fresenius Kabi, Hospira, JMS, Nipro, Terumo, Animas, Medtronic, and Smiths Medical.
- PRICE
-
$2500$4000